Fidelity Investments’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $56M | Buy |
1,018,814
+738,368
| +263% | +$30.2M | ﹤0.01% | 1475 |
|
|
2026
Q1 | $9.32M | Buy |
280,446
+53,450
| +24% | +$1.59M | ﹤0.01% | 2068 |
|
|
2025
Q4 | $6.77M | Sell |
226,996
-484,347
| -68% | -$15.8M | ﹤0.01% | 2178 |
|
|
2025
Q3 | $25.7M | Sell |
711,343
-840,630
| -54% | -$27.7M | ﹤0.01% | 1665 |
|
|
2025
Q2 | $55.9M | Sell |
1,551,973
-191,381
| -11% | -$7.13M | ﹤0.01% | 1355 |
|
|
2025
Q1 | $68.7M | Buy |
1,743,354
+711,935
| +69% | +$24M | ﹤0.01% | 1239 |
|
|
2024
Q4 | $31M | Sell |
1,031,419
-152,739
| -13% | -$4.38M | ﹤0.01% | 1570 |
|
|
2024
Q3 | $27.7M | Sell |
1,184,158
-31,419
| -3% | -$686K | ﹤0.01% | 1601 |
|
|
2024
Q2 | $21.6M | Sell |
1,215,577
-180,975
| -13% | -$2.89M | ﹤0.01% | 1621 |
|
|
2024
Q1 | $21.2M | Sell |
1,396,552
-182,959
| -12% | -$2.91M | ﹤0.01% | 1632 |
|
|
2023
Q4 | $27M | Buy |
1,579,511
+650,673
| +70% | +$7.56M | ﹤0.01% | 1513 |
|
|
2023
Q3 | $7.77M | Sell |
928,838
-5,152,059
| -85% | -$71.8M | ﹤0.01% | 1909 |
|
|
2023
Q2 | $151M | Buy |
6,080,897
+260,861
| +4% | +$6.74M | 0.01% | 833 |
|
|
2023
Q1 | $87.5M | Sell |
5,820,036
-1,368,826
| -19% | -$20.8M | 0.01% | 1030 |
|
|
2022
Q4 | $85M | Sell |
7,188,862
-531,362
| -7% | -$3.86M | 0.01% | 1029 |
|
|
2022
Q3 | $45.7M | Sell |
7,720,224
-334,237
| -4% | -$2.19M | ﹤0.01% | 1276 |
|
|
2022
Q2 | $34.2M | Sell |
8,054,461
-12,274,380
| -60% | -$76.6M | ﹤0.01% | 1426 |
|
|
2022
Q1 | $193M | Sell |
20,328,841
-392,590
| -2% | -$4.54M | 0.02% | 789 |
|
|
2021
Q4 | $394M | Buy |
20,721,431
+1,453,429
| +8% | +$37.7M | 0.03% | 541 |
|
|
2021
Q3 | $641M | Buy |
19,268,002
+590,487
| +3% | +$18.3M | 0.05% | 349 |
|
|
2021
Q2 | $725M | Buy |
18,677,515
+706,864
| +4% | +$27.8M | 0.06% | 321 |
|
|
2021
Q1 | $866M | Buy |
17,970,651
+3,143,515
| +21% | +$151M | 0.07% | 250 |
|
|
2020
Q4 | $771M | Buy |
14,827,136
+3,865,631
| +35% | +$131M | 0.07% | 275 |
|
|
2020
Q3 | $293M | Sell |
10,961,505
-1,691,781
| -13% | -$38.9M | 0.03% | 489 |
|
|
2020
Q2 | $246M | Buy |
12,653,286
+3,130,045
| +33% | +$50.4M | 0.03% | 524 |
|
|
2020
Q1 | $93.7M | Buy |
9,523,241
+7,769,797
| +443% | +$98.1M | 0.01% | 781 |
|
|
2019
Q4 | $19.5M | Sell |
1,753,444
-82,476
| -4% | -$627K | ﹤0.01% | 1605 |
|
|
2019
Q3 | $10.3M | Sell |
1,835,920
-191,117
| -9% | -$1.33M | ﹤0.01% | 1813 |
|
|
2019
Q2 | $17.5M | Sell |
2,027,037
-375,000
| -16% | -$2.83M | ﹤0.01% | 1674 |
|
|
2019
Q1 | $19.3M | Sell |
2,402,037
-321,400
| -12% | -$1.74M | ﹤0.01% | 1619 |
|
|
2018
Q4 | $11.2M | Sell |
2,723,437
-221,296
| -8% | -$1.1M | ﹤0.01% | 1766 |
|
|
2018
Q3 | $16.5M | Sell |
2,944,733
-621,700
| -17% | -$7.1M | ﹤0.01% | 1761 |
|
|
2018
Q2 | $46.9M | Sell |
3,566,433
-1,162,800
| -25% | -$16M | 0.01% | 1305 |
|
|
2018
Q1 | $67.2M | Sell |
4,729,233
-221,980
| -4% | -$2.84M | 0.01% | 1165 |
|
|
2017
Q4 | $40.6M | Sell |
4,951,213
-1,500,500
| -23% | -$13.1M | ﹤0.01% | 1398 |
|
|
2017
Q3 | $76.5M | Hold |
6,451,713
| – | – | 0.01% | 1100 |
|
|
2017
Q2 | $64.8M | Hold |
6,451,713
| – | – | 0.01% | 1184 |
|
|
2017
Q1 | $75.2M | Buy |
6,451,713
+2,660,949
| +70% | +$19.1M | 0.01% | 1108 |
|
|
2016
Q4 | $17.6M | Sell |
3,790,764
-1,069,000
| -22% | -$6.27M | ﹤0.01% | 1730 |
|
|
2016
Q3 | $37.6M | Hold |
4,859,764
| – | – | 0.01% | 1423 |
|
|
2016
Q2 | $29.4M | Sell |
4,859,764
-1,165,661
| -19% | -$9.48M | ﹤0.01% | 1501 |
|
|
2016
Q1 | $51.3M | Sell |
6,025,425
-236,882
| -4% | -$2.07M | 0.01% | 1237 |
|
|
2015
Q4 | $74.7M | Buy |
6,262,307
+299,006
| +5% | +$3.78M | 0.01% | 1093 |
|
|
2015
Q3 | $60.1M | Buy |
5,963,301
+2,088,459
| +54% | +$31.1M | 0.01% | 1163 |
|
|
2015
Q2 | $64.3M | Buy |
3,874,842
+813,772
| +27% | +$12.9M | 0.01% | 1228 |
|
|
2015
Q1 | $47.4M | Buy |
3,061,070
+1,133,267
| +59% | +$17.2M | 0.01% | 1355 |
|
|
2014
Q4 | $30.5M | Buy |
+1,927,803
| New | +$25.1M | ﹤0.01% | 1556 |
|
|
2013
Q4 | – | Sell |
-43,600
| Closed | -$222K | – | 2685 |
|
|
2013
Q3 | $222K | Buy |
+43,600
| New | +$267K | ﹤0.01% | 2571 |
|
Other funds holding TGTX
SCM
CAM
Fidelity Investments's TGTX Position: Q2 2026 in Review
Fidelity Investments increased its TG Therapeutics (TGTX) stake by 263% in Q2 2026, buying an estimated $30.2M and bringing the position to 1,018,814 shares worth $56M. The position accounts for ﹤0.01% of the portfolio, ranked #1475.
Fidelity Investments first reported a position in TGTX in Q3 2013 and has held it in 48 quarters since. The position peaked at $866M in Q1 2021. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Fidelity Investments held 1,018,814 shares of TG Therapeutics worth $56M as of Q2 2026.
- Fidelity Investments bought 738,368 TG Therapeutics shares in Q2 2026, an estimated $30.2M.
- TG Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1475 holding.
- Fidelity Investments first reported a position in TG Therapeutics in Q3 2013 and has held it in 48 quarters since.
- Fidelity Investments's TG Therapeutics position peaked at $866M in Q1 2021.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.